Search

Search Results

• The use of the PD-1/PD-L1 pathway as an immunotherapy in oncological diseases, autoimmune diseases and infectious diseases

  Dominika Katarzyna Madras, Agata Agnieszka Rocka, Klaudia Daria Szumna, Patryk Piotr Jasielski, Faustyna Piędel

  113-124

  2020-04-13
• Determination of biochemical indicators when modeling HIPEC with cisplatin on rats

  E. D. Pykhtieieva, A. M. Tretyakov, A. I. Gozhenko, E. G. Pykhtieieva

  626-631

  2019-03-29
• Experimental study of metallothionein synthesis in modeling hyperthermic intraoperative intraperitoneal chemoperfusion with cysplatinum

  E. D. Pykhtieieva, E. G. Pykhtieieva, A. I. Gozhenko

  391-396

  2018-01-31
• Life quality indexes in neo-adjuvant chemotherapy in laryngopharynx cancer patients

  N. V. Grin

  1291-1299

  2019-09-30
• Changes of microelement homeostasis when modeling HIPEC with cisplatine

  E. D. Pykhtieieva, A. I. Gozhenko, E. G. Pykhtieieva, D. V. Bolshoy, A. M. Tretyakov

  569-577

  2019-02-28
• Novel immunotherapy in the management of advanced urothelial cancer - review of the literature

  Paulina Chmiel, Martyna Kłosińska, Agnieszka Kaczyńska

  348-357

  2022-08-09
• Evaluation of a renoprotective potential of organospecific peptides under the conditions of acute kidney injury of different etiology

  T. S. Shchudrova, I. I. Zamorskii, O. P. Korotun

  221-227

  2018-01-31
• Unexpectedly long progression-free time in a patient with squamous cell carcinoma of the lung treated with Nivolumab – a case study

  Katarzyna Szklener, Klaudia Piwowar, Jakub Klas, Natalia Kluz, Sławomir Mańdziuk

  509-517

  2022-08-15